Reconstitution of transport-active multidrug resistance protein 2 (MRP2; ABCC2) in proteoliposomes

Wolfgang Hagmann1, Jana Schubert, Jörg König

  • 1Abteilung Tumorbiochemie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Biological Chemistry
|September 12, 2002
PubMed

Insights

Researchers purified and reconstituted the apical multidrug resistance protein MRP2 (ABCC2) into proteoliposomes, demonstrating its active transport function for substrates like LTC4. This breakthrough enables further study of MRP2 interactions in polarized cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • The apical multidrug resistance protein MRP2 (ABCC2) functions as an ATP-dependent export pump for anionic conjugates in polarized cells.
  • MRP2 shares limited amino acid identity (48%) with its paralog, MRP1 (ABCC1).

Purpose of the Study:

  • To reconstitute purified recombinant MRP2 (ABCC2) into proteoliposomes to demonstrate its functional activity in substrate transport.
  • To characterize the kinetic parameters and inhibition of MRP2 transport.
  • To investigate the interaction of MRP2 with the chaperone calnexin.

Main Methods:

  • Purification of recombinant MRP2 (ABCC2).
  • Reconstitution of purified MRP2 into proteoliposomes.
  • Assay of substrate transport (LTC4) and ATP dependence.
  • Determination of kinetic parameters (Km) and inhibition by MK571.
  • Binding and co-reconstitution studies with calnexin.

Main Results:

  • Purified recombinant MRP2 reconstituted in proteoliposomes exhibited active substrate transport.
  • Kinetic analysis revealed Km values for ATP (560 µM) and LTC4 (450 nM).
  • Transport activity was dependent on MRP2 protein amount and inhibited by MK571.
  • MRP2 preferentially associates with calnexin, but calnexin is not essential for MRP2's LTC4 transport function.

Conclusions:

  • This study reports the first successful reconstitution of transport-active purified recombinant MRP2.
  • The characterized transport activity and inhibition provide a basis for further investigation.
  • Purified MRP2 can be used to identify additional interacting proteins in the apical membrane of polarized cells.

Related Concept Videos

Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...